Elan Corp., Plc Adr
   

Elan ( ELN) Stock Price

Elan stock quote | Elan company information | Elan Stock Chart | Elan Stock News

Company Description : Elan Corporation, PLC is a neuroscience-based biotechnology company, which operates its business in two areas BioNeurology and EDT. url: www.elan.com

Name:
Elan Corp., Plc Adr		 Symbol:
NYSE:ELN		 Stock Market:
New York Stock Exchange		 Type:
Equity		 ISIN:
US2841312083		 Description:
 ChangeChange %CurBidAskHighLowOpenVolumeTimeA
-0.03-0.2313.0113.100112.9813.0736521211:25:36
stock Prices on this screen are 15 minutes delayed

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec & Elan - ..
For Immediate Release Chicago, IL – May 21, 2012 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Dr. Reddy’s Laboratories...

Free Elan Stock Charts

Elan Historical Stock Chart
Elan Historical Stock Chart
Elan Monthly Stock Chart
Elan Monthly Stock Chart		Elan Intraday stock chart
Elan Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Weighted Moving Average and Choppiness.

Get the Latest Elan stock Price, quotes, trades and FREE Elan stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Elan (ELN) and other New York Stock Exchange listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Elan News & Message Board Discussion

Latest Elan News Headlines
DateTimeSource
HeadlineMore ELN News
05/21/20124:30AMZACKSThe Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec & Elan - ..
05/18/201212:10PMZACKSRevenues Skyrocket at Merged Alkermes - Analyst Blog
05/18/201211:41AMZACKSData on Elan & Biogen's Tysabri - Analyst Blog
05/17/20125:27PMEDGARReport of Foreign Issuer
05/17/20123:40PMBWNew Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine
05/17/20123:40PMBWNew Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine
05/08/20128:45AMZACKSEarnings Beat at PDL BioPharma - Analyst Blog
05/04/20121:52PMZACKSRevenues Climb at Acorda - Analyst Blog
05/02/20123:30PMEDGARReport of Foreign Issuer
05/01/20125:16PMEDGARReport of Foreign Issuer
05/01/201212:41PMDJN2nd UPDATE: Biogen 1Q Profit Up, But Hurt By Purchasing Issue
05/01/201211:09AMDJNUPDATE: Biogen 1Q Profit Up, But Hurt By Purchasing Issue

Elan Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Elan company information and fundamental data for other USA Equity companies. More than 100 separate statistics including average collection period and payout ratio.

Latest Elan Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  100 13.01 05/21/2012 11:25AM USD


 



Elan Stock Prices supplied by NYSE.
Free NYSE stock prices are delayed by at least 15 minutes. Realtime NYSE stock prices available.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Affiliate Scheme
Copyright 1999-2011 ADVFN PLC. Copyright Notice & Privacy Policy :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
43 site:2us nyse eln120521 11:40